Ask an Advocate

Why was my GLP-1 weight loss drug denied by insurance? 

GLP-1 medications like Wegovy and Zepbound have become widely known for their effectiveness in supporting weight loss. However, insurance denials for these medications are increasingly common—especially in 2025, as coverage requirements have become more strict. So, what’s behind these denials? 

1. These Drugs Often Require Authorization or Exceptions 

Unlike many standard prescriptions, GLP-1 drugs typically aren’t automatically covered. Most insurance carriers require prior authorization or an exception request to be submitted and approved before they’ll provide coverage. Even then, approval isn’t guaranteed. 

To qualify, members generally need to meet one of the following clinical criteria: 

• A BMI ≥ 30 kg/m², OR 
• A BMI ≥ 27 kg/m² with at least one indicator of increased cardiovascular risk such as: 
  • Heart disease 
  • High blood pressure (hypertension) 
  • High cholesterol (dyslipidemia) 
  • Sleep apnea or other obesity-related conditions

2. Insurance Criteria Got Stricter in 2025 

In 2025, many insurers tightened approval standards, citing growing demand and rising costs. Even patients who qualified in previous years might now face new hurdles. 

Several key factors are driving this approach: 

Cost

GLP-1 medications are expensive—averaging $1,300 per month. Covering them widely could lead to significantly higher healthcare costs, which ultimately affects employer and employee premiums. 

Alternative Approaches 

Some insurers view GLP-1 drugs as short-term fixes. Clinical studies show that once medication is stopped, weight is often regained quickly. That’s why many plans are pushing for comprehensive weight loss programs that include lifestyle coaching and long-term behavior change alongside any medication. 

Long-Term Safety and Efficacy 

Though GLP-1 medications show promising results, long-term data is still emerging. Insurance providers remain cautious about covering treatments with limited safety profiles or potential unknown side effects—especially for long-term use. 

Not an ACA Mandated Benefit 

Weight loss drugs like Wegovy and Zepbound are not required coverage under the Affordable Care Act. This gives insurers discretion in whether—and how—they cover them. 

3. What About Compounded GLP-1 Drugs? 

Compounded versions of Wegovy or Zepbound may seem like a more affordable alternative, but they come with risks. These medications bypass FDA approval, which means: 

• They may not contain accurate doses or ingredients 
• Manufacturing processes may not meet safety standards
• Effectiveness and safety aren’t guaranteed 

In fact, the FDA has issued warnings about the use of compounded GLP-1 drugs due to potential health risks. 

If you’re considering compounded versions, it’s critical to work through a reputable weight loss program that includes: 

• Medical consultation and follow-ups with a licensed U.S. physician 
• Prescription-only access 
• A U.S.-licensed pharmacy with a physical location 
• A licensed pharmacist on staff 
• Lifestyle coaching or support integrated into the plan 

4. Examples of Reputable GLP-1 Weight Loss Programs 

Here are a few programs that combine medical oversight, personalized support, and FDA-compliant access to weight loss medications: 

• PlushCare – Online MD visits, customized treatment plans, and medication access 
• Found – Personalized programs with virtual care and coaching 
• Calibrate – GLP-1 medications paired with lifestyle intervention and digital tracking 
• Mayo Clinic Diet for Weight-Loss Medications – Structured program with medical oversight 
• Sequence – Focus  on lifestyle changes and medical weight loss through virtual visits
• CVS Weight Management – Combines GLP-1 prescriptions with care team support and coaching 

If you have questions about your healthcare plan or access to care, contact our Advocacy Team by calling 855-662-1029 or emailing AdvocateServices@morrisgarritano.com